Results 311 to 320 of about 133,046 (390)
Role of B-Cell Inhibition in Autoimmune Hepatitis: Lessons Learnt From Systemic Lupus Erythematosus. [PDF]
Duggal S, Sairam S.
europepmc +1 more source
Recent developments in liver transplantation [PDF]
Brettschneider, L, Groth, CG, Starzl, TE
core
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Khaled Ezzedine+10 more
wiley +1 more source
Aims The aim of study was to generate quantitative data on the abundance of drug‐metabolizing enzymes and transporters (DMETs) in inflamed and non‐inflamed Crohn's disease (CD) ileum and colon, for incorporation into physiologically based pharmacokinetic (PBPK) models, enabling prediction of oral drugs' pharmacokinetics (PK) perturbation in CD patients.
Sarah Alrubia+4 more
wiley +1 more source
Double Trouble: Drug-Induced Autoimmune Hepatitis (AIH)-Primary Biliary Cholangitis (PBC) Overlap Syndrome Triggered by Hydralazine. [PDF]
Chaudhuri U+4 more
europepmc +1 more source
Abstract Objective To evaluate the trends, safety, and feasibility of a trial of labor after cesarean (TOLAC) among kidney and liver transplant recipients. Methods This was a retrospective cohort study using the Transplant Pregnancy Registry International.
Anjali Walia+7 more
wiley +1 more source
Effect of cyclosporin-A on hepatic and renal allograft mononuclear cell infiltration [PDF]
Paradis, IL, Rabin, BS, Si, L
core
FIGO guideline on liver disease and pregnancy
Abstract The number of women entering pregnancy with chronic liver disease is rising. Gestational liver disorders affect 3% of the pregnant population. Both can be associated with significant maternal and fetal morbidity and mortality. European guidance has recently been published to inform management.
Melanie Nana+24 more
wiley +1 more source
Using pharmacogenomics to personalise drug therapy: which drugs, when and how. [PDF]
Stocker SL, Polasek TM.
europepmc +1 more source